nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1A—stomach cancer	0.658	1	CbGaD
Naratriptan—Sumatriptan—HTR1A—stomach cancer	0.00133	0.365	CrCbGaD
Naratriptan—Eletriptan—CYP2A6—stomach cancer	0.00124	0.34	CrCbGaD
Naratriptan—Eletriptan—HTR1A—stomach cancer	0.00107	0.295	CrCbGaD
Naratriptan—Myalgia—Capecitabine—stomach cancer	0.000176	0.000666	CcSEcCtD
Naratriptan—Confusional state—Docetaxel—stomach cancer	0.000176	0.000665	CcSEcCtD
Naratriptan—Anxiety—Capecitabine—stomach cancer	0.000176	0.000664	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000175	0.00066	CcSEcCtD
Naratriptan—Anaphylactic shock—Docetaxel—stomach cancer	0.000175	0.000659	CcSEcCtD
Naratriptan—Oedema—Docetaxel—stomach cancer	0.000175	0.000659	CcSEcCtD
Naratriptan—Discomfort—Capecitabine—stomach cancer	0.000174	0.000658	CcSEcCtD
Naratriptan—Infection—Docetaxel—stomach cancer	0.000173	0.000655	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—stomach cancer	0.000173	0.000654	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—stomach cancer	0.000173	0.000653	CcSEcCtD
Naratriptan—Diarrhoea—Irinotecan—stomach cancer	0.000173	0.000653	CcSEcCtD
Naratriptan—Dry mouth—Capecitabine—stomach cancer	0.000172	0.000651	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—stomach cancer	0.000172	0.000649	CcSEcCtD
Naratriptan—Shock—Docetaxel—stomach cancer	0.000172	0.000649	CcSEcCtD
Naratriptan—Nervous system disorder—Docetaxel—stomach cancer	0.000171	0.000647	CcSEcCtD
Naratriptan—Pruritus—Fluorouracil—stomach cancer	0.000171	0.000646	CcSEcCtD
Naratriptan—Thrombocytopenia—Docetaxel—stomach cancer	0.000171	0.000645	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—stomach cancer	0.000171	0.000645	CcSEcCtD
Naratriptan—Confusional state—Capecitabine—stomach cancer	0.00017	0.000644	CcSEcCtD
Naratriptan—Skin disorder—Docetaxel—stomach cancer	0.00017	0.00064	CcSEcCtD
Naratriptan—Oedema—Capecitabine—stomach cancer	0.000169	0.000638	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—stomach cancer	0.000169	0.000637	CcSEcCtD
Naratriptan—Infection—Capecitabine—stomach cancer	0.000168	0.000634	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000167	0.000632	CcSEcCtD
Naratriptan—Dizziness—Irinotecan—stomach cancer	0.000167	0.000631	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—stomach cancer	0.000167	0.000629	CcSEcCtD
Naratriptan—Shock—Capecitabine—stomach cancer	0.000166	0.000628	CcSEcCtD
Naratriptan—Nervous system disorder—Capecitabine—stomach cancer	0.000166	0.000626	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—stomach cancer	0.000166	0.000626	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—stomach cancer	0.000165	0.000625	CcSEcCtD
Naratriptan—Thrombocytopenia—Capecitabine—stomach cancer	0.000165	0.000625	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—stomach cancer	0.000165	0.000624	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—stomach cancer	0.000165	0.000623	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—stomach cancer	0.000164	0.000621	CcSEcCtD
Naratriptan—Skin disorder—Capecitabine—stomach cancer	0.000164	0.00062	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—stomach cancer	0.000164	0.000618	CcSEcCtD
Naratriptan—Hyperhidrosis—Capecitabine—stomach cancer	0.000163	0.000617	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—stomach cancer	0.000163	0.000616	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—stomach cancer	0.000161	0.000607	CcSEcCtD
Naratriptan—Vomiting—Irinotecan—stomach cancer	0.000161	0.000606	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—stomach cancer	0.00016	0.000605	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—stomach cancer	0.00016	0.000604	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—stomach cancer	0.00016	0.000604	CcSEcCtD
Naratriptan—Rash—Irinotecan—stomach cancer	0.000159	0.000601	CcSEcCtD
Naratriptan—Dermatitis—Irinotecan—stomach cancer	0.000159	0.000601	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000159	0.000601	CcSEcCtD
Naratriptan—Chills—Methotrexate—stomach cancer	0.000159	0.0006	CcSEcCtD
Naratriptan—Headache—Irinotecan—stomach cancer	0.000158	0.000597	CcSEcCtD
Naratriptan—Hypotension—Capecitabine—stomach cancer	0.000158	0.000596	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—stomach cancer	0.000157	0.000592	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—stomach cancer	0.000156	0.000591	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—stomach cancer	0.000156	0.00059	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—stomach cancer	0.000156	0.000588	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—stomach cancer	0.000155	0.000586	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—stomach cancer	0.000155	0.000584	CcSEcCtD
Naratriptan—Erythema—Methotrexate—stomach cancer	0.000154	0.000582	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—stomach cancer	0.000154	0.000582	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000154	0.000582	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—stomach cancer	0.000154	0.000581	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—stomach cancer	0.000154	0.000581	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—stomach cancer	0.000153	0.000579	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—stomach cancer	0.000153	0.000576	CcSEcCtD
Naratriptan—Rash—Fluorouracil—stomach cancer	0.000153	0.000576	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—stomach cancer	0.000152	0.000575	CcSEcCtD
Naratriptan—Paraesthesia—Capecitabine—stomach cancer	0.000152	0.000573	CcSEcCtD
Naratriptan—Headache—Fluorouracil—stomach cancer	0.000152	0.000572	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000151	0.000569	CcSEcCtD
Naratriptan—Dyspnoea—Capecitabine—stomach cancer	0.000151	0.000569	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—stomach cancer	0.000151	0.000568	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—stomach cancer	0.00015	0.000568	CcSEcCtD
Naratriptan—Nausea—Irinotecan—stomach cancer	0.00015	0.000566	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—stomach cancer	0.00015	0.000565	CcSEcCtD
Naratriptan—Constipation—Docetaxel—stomach cancer	0.000149	0.000564	CcSEcCtD
Naratriptan—Pain—Docetaxel—stomach cancer	0.000149	0.000564	CcSEcCtD
Naratriptan—Chills—Epirubicin—stomach cancer	0.000149	0.000562	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—stomach cancer	0.000148	0.000559	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—stomach cancer	0.000146	0.000553	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000146	0.000551	CcSEcCtD
Naratriptan—Fatigue—Capecitabine—stomach cancer	0.000146	0.00055	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—stomach cancer	0.000145	0.000549	CcSEcCtD
Naratriptan—Constipation—Capecitabine—stomach cancer	0.000145	0.000546	CcSEcCtD
Naratriptan—Pain—Capecitabine—stomach cancer	0.000145	0.000546	CcSEcCtD
Naratriptan—Erythema—Epirubicin—stomach cancer	0.000144	0.000545	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—stomach cancer	0.000144	0.000543	CcSEcCtD
Naratriptan—Nausea—Fluorouracil—stomach cancer	0.000144	0.000543	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—stomach cancer	0.000143	0.00054	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—stomach cancer	0.000143	0.00054	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—stomach cancer	0.000142	0.000538	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—stomach cancer	0.000142	0.000537	CcSEcCtD
Naratriptan—Feeling abnormal—Capecitabine—stomach cancer	0.000139	0.000526	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—stomach cancer	0.000139	0.000525	CcSEcCtD
Naratriptan—Malaise—Methotrexate—stomach cancer	0.000139	0.000525	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—stomach cancer	0.000139	0.000524	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—stomach cancer	0.000139	0.000523	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—stomach cancer	0.000139	0.000523	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—stomach cancer	0.000138	0.000521	CcSEcCtD
Naratriptan—Chills—Doxorubicin—stomach cancer	0.000138	0.00052	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—stomach cancer	0.000137	0.000517	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—stomach cancer	0.000136	0.000513	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—stomach cancer	0.000136	0.000512	CcSEcCtD
Naratriptan—Cough—Methotrexate—stomach cancer	0.000135	0.000508	CcSEcCtD
Naratriptan—Urticaria—Capecitabine—stomach cancer	0.000134	0.000507	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—stomach cancer	0.000134	0.000506	CcSEcCtD
Naratriptan—Body temperature increased—Capecitabine—stomach cancer	0.000134	0.000505	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—stomach cancer	0.000134	0.000504	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—stomach cancer	0.000133	0.000504	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—stomach cancer	0.000133	0.000504	CcSEcCtD
Naratriptan—Agitation—Epirubicin—stomach cancer	0.000133	0.000501	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—stomach cancer	0.000131	0.000496	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—stomach cancer	0.000131	0.000496	CcSEcCtD
Naratriptan—Malaise—Epirubicin—stomach cancer	0.00013	0.000491	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—stomach cancer	0.00013	0.00049	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—stomach cancer	0.00013	0.000489	CcSEcCtD
Naratriptan—Syncope—Epirubicin—stomach cancer	0.000129	0.000489	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—stomach cancer	0.000129	0.000486	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—stomach cancer	0.000128	0.000485	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—stomach cancer	0.000128	0.000481	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—stomach cancer	0.000127	0.000479	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—stomach cancer	0.000127	0.000479	CcSEcCtD
Naratriptan—Cough—Epirubicin—stomach cancer	0.000126	0.000475	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—stomach cancer	0.000126	0.000475	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—stomach cancer	0.000126	0.000475	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—stomach cancer	0.000125	0.000473	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—stomach cancer	0.000125	0.000472	CcSEcCtD
Naratriptan—Infection—Methotrexate—stomach cancer	0.000125	0.000472	CcSEcCtD
Naratriptan—Hypersensitivity—Capecitabine—stomach cancer	0.000125	0.00047	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000124	0.000468	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—stomach cancer	0.000124	0.000466	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—stomach cancer	0.000123	0.000466	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—stomach cancer	0.000123	0.000466	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—stomach cancer	0.000123	0.000465	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—stomach cancer	0.000123	0.000464	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—stomach cancer	0.000123	0.000464	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—stomach cancer	0.000123	0.000463	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—stomach cancer	0.000122	0.000462	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—stomach cancer	0.000122	0.000462	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—stomach cancer	0.000122	0.000459	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—stomach cancer	0.000121	0.000458	CcSEcCtD
Naratriptan—Asthenia—Capecitabine—stomach cancer	0.000121	0.000458	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—stomach cancer	0.00012	0.000455	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—stomach cancer	0.00012	0.000454	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—stomach cancer	0.00012	0.000453	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—stomach cancer	0.00012	0.000452	CcSEcCtD
Naratriptan—Pruritus—Capecitabine—stomach cancer	0.00012	0.000452	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—stomach cancer	0.000119	0.000451	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—stomach cancer	0.000119	0.000448	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—stomach cancer	0.000118	0.000445	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—stomach cancer	0.000118	0.000445	CcSEcCtD
Naratriptan—Oedema—Epirubicin—stomach cancer	0.000118	0.000445	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—stomach cancer	0.000118	0.000444	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—stomach cancer	0.000117	0.000443	CcSEcCtD
Naratriptan—Infection—Epirubicin—stomach cancer	0.000117	0.000442	CcSEcCtD
Naratriptan—Cough—Doxorubicin—stomach cancer	0.000116	0.00044	CcSEcCtD
Naratriptan—Shock—Epirubicin—stomach cancer	0.000116	0.000437	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—stomach cancer	0.000116	0.000437	CcSEcCtD
Naratriptan—Diarrhoea—Capecitabine—stomach cancer	0.000116	0.000437	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—stomach cancer	0.000115	0.000436	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—stomach cancer	0.000115	0.000436	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—stomach cancer	0.000115	0.000435	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000115	0.000433	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—stomach cancer	0.000114	0.000432	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—stomach cancer	0.000114	0.00043	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—stomach cancer	0.000114	0.000429	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—stomach cancer	0.000114	0.000429	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—stomach cancer	0.000113	0.000428	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—stomach cancer	0.000113	0.000427	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—stomach cancer	0.000112	0.000424	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—stomach cancer	0.000112	0.000424	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—stomach cancer	0.000112	0.000422	CcSEcCtD
Naratriptan—Dizziness—Capecitabine—stomach cancer	0.000112	0.000422	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—stomach cancer	0.000111	0.00042	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—stomach cancer	0.000111	0.000419	CcSEcCtD
Naratriptan—Rash—Docetaxel—stomach cancer	0.00011	0.000416	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—stomach cancer	0.00011	0.000415	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—stomach cancer	0.00011	0.000415	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—stomach cancer	0.00011	0.000415	CcSEcCtD
Naratriptan—Headache—Docetaxel—stomach cancer	0.000109	0.000413	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000109	0.000411	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—stomach cancer	0.000109	0.000411	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000109	0.00041	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—stomach cancer	0.000108	0.00041	CcSEcCtD
Naratriptan—Infection—Doxorubicin—stomach cancer	0.000108	0.000409	CcSEcCtD
Naratriptan—Pain—Methotrexate—stomach cancer	0.000108	0.000406	CcSEcCtD
Naratriptan—Vomiting—Capecitabine—stomach cancer	0.000107	0.000406	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000107	0.000405	CcSEcCtD
Naratriptan—Shock—Doxorubicin—stomach cancer	0.000107	0.000405	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—stomach cancer	0.000107	0.000403	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000107	0.000403	CcSEcCtD
Naratriptan—Rash—Capecitabine—stomach cancer	0.000107	0.000402	CcSEcCtD
Naratriptan—Dermatitis—Capecitabine—stomach cancer	0.000106	0.000402	CcSEcCtD
Naratriptan—Headache—Capecitabine—stomach cancer	0.000106	0.0004	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—stomach cancer	0.000106	0.0004	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—stomach cancer	0.000106	0.000399	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000105	0.000398	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—stomach cancer	0.000105	0.000396	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—stomach cancer	0.000105	0.000395	CcSEcCtD
Naratriptan—Nausea—Docetaxel—stomach cancer	0.000104	0.000392	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—stomach cancer	0.000104	0.000392	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—stomach cancer	0.000102	0.000384	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000102	0.000384	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—stomach cancer	0.000102	0.000383	CcSEcCtD
Naratriptan—Pain—Epirubicin—stomach cancer	0.000101	0.00038	CcSEcCtD
Naratriptan—Constipation—Epirubicin—stomach cancer	0.000101	0.00038	CcSEcCtD
Naratriptan—Nausea—Capecitabine—stomach cancer	0.0001	0.000379	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—stomach cancer	0.0001	0.000377	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—stomach cancer	9.95e-05	0.000376	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.93e-05	0.000375	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—stomach cancer	9.78e-05	0.000369	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—stomach cancer	9.71e-05	0.000367	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—stomach cancer	9.7e-05	0.000366	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—stomach cancer	9.69e-05	0.000366	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.41e-05	0.000355	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—stomach cancer	9.39e-05	0.000355	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—stomach cancer	9.35e-05	0.000353	CcSEcCtD
Naratriptan—Pain—Doxorubicin—stomach cancer	9.32e-05	0.000352	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—stomach cancer	9.32e-05	0.000352	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—stomach cancer	9.31e-05	0.000352	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—stomach cancer	9.27e-05	0.00035	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—stomach cancer	9.03e-05	0.000341	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—stomach cancer	8.98e-05	0.000339	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—stomach cancer	8.9e-05	0.000336	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—stomach cancer	8.68e-05	0.000328	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—stomach cancer	8.66e-05	0.000327	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—stomach cancer	8.61e-05	0.000325	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—stomach cancer	8.61e-05	0.000325	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—stomach cancer	8.45e-05	0.000319	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—stomach cancer	8.33e-05	0.000315	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—stomach cancer	8.32e-05	0.000314	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—stomach cancer	8.06e-05	0.000304	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—stomach cancer	8.03e-05	0.000303	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—stomach cancer	8e-05	0.000302	CcSEcCtD
Naratriptan—Rash—Methotrexate—stomach cancer	7.93e-05	0.0003	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—stomach cancer	7.93e-05	0.000299	CcSEcCtD
Naratriptan—Headache—Methotrexate—stomach cancer	7.88e-05	0.000298	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—stomach cancer	7.82e-05	0.000295	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—stomach cancer	7.79e-05	0.000294	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—stomach cancer	7.71e-05	0.000291	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—stomach cancer	7.49e-05	0.000283	CcSEcCtD
Naratriptan—Nausea—Methotrexate—stomach cancer	7.47e-05	0.000282	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—stomach cancer	7.45e-05	0.000282	CcSEcCtD
Naratriptan—Rash—Epirubicin—stomach cancer	7.42e-05	0.00028	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—stomach cancer	7.42e-05	0.00028	CcSEcCtD
Naratriptan—Headache—Epirubicin—stomach cancer	7.38e-05	0.000279	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—stomach cancer	7.2e-05	0.000272	CcSEcCtD
Naratriptan—Nausea—Epirubicin—stomach cancer	6.99e-05	0.000264	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—stomach cancer	6.93e-05	0.000262	CcSEcCtD
Naratriptan—Rash—Doxorubicin—stomach cancer	6.87e-05	0.000259	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—stomach cancer	6.86e-05	0.000259	CcSEcCtD
Naratriptan—Headache—Doxorubicin—stomach cancer	6.83e-05	0.000258	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—stomach cancer	6.47e-05	0.000244	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—SMAD4—stomach cancer	3.31e-05	0.00045	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL8—stomach cancer	3.28e-05	0.000445	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKR1C3—stomach cancer	3.26e-05	0.000443	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FST—stomach cancer	3.26e-05	0.000442	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADRB2—stomach cancer	3.24e-05	0.00044	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HSPB1—stomach cancer	3.19e-05	0.000434	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGTR2—stomach cancer	3.19e-05	0.000434	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HBEGF—stomach cancer	3.18e-05	0.000433	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ENO1—stomach cancer	3.17e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—F2R—stomach cancer	3.16e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BMP2—stomach cancer	3.16e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FYN—stomach cancer	3.14e-05	0.000427	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GAST—stomach cancer	3.14e-05	0.000427	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RGS2—stomach cancer	3.14e-05	0.000427	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HSPB1—stomach cancer	3.12e-05	0.000425	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGTR2—stomach cancer	3.12e-05	0.000425	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKR1C3—stomach cancer	3.1e-05	0.000422	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BMP2—stomach cancer	3.09e-05	0.00042	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—F2R—stomach cancer	3.09e-05	0.00042	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1A—stomach cancer	3.07e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKR1C3—stomach cancer	3.04e-05	0.000413	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1A—stomach cancer	3.01e-05	0.000409	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGG—stomach cancer	2.98e-05	0.000405	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL8—stomach cancer	2.98e-05	0.000404	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PRKCB—stomach cancer	2.97e-05	0.000404	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ANXA1—stomach cancer	2.97e-05	0.000403	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGFR2—stomach cancer	2.95e-05	0.000401	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADRB2—stomach cancer	2.94e-05	0.000399	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PRKCB—stomach cancer	2.91e-05	0.000396	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ANXA1—stomach cancer	2.9e-05	0.000395	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PPP2R1A—stomach cancer	2.88e-05	0.000391	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRB1—stomach cancer	2.87e-05	0.00039	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKAA1—stomach cancer	2.87e-05	0.00039	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CD44—stomach cancer	2.82e-05	0.000383	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRB1—stomach cancer	2.81e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RBP4—stomach cancer	2.77e-05	0.000376	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL8—stomach cancer	2.77e-05	0.000376	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—HRAS—stomach cancer	2.75e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RPS6—stomach cancer	2.74e-05	0.000373	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IRS2—stomach cancer	2.7e-05	0.000367	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PRKCB—stomach cancer	2.7e-05	0.000367	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6ST—stomach cancer	2.69e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RPS6—stomach cancer	2.69e-05	0.000365	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PRKCB—stomach cancer	2.64e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6ST—stomach cancer	2.63e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CAV1—stomach cancer	2.62e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOA1—stomach cancer	2.62e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HBEGF—stomach cancer	2.52e-05	0.000343	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PRKCB—stomach cancer	2.49e-05	0.000339	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6ST—stomach cancer	2.48e-05	0.000338	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HBEGF—stomach cancer	2.47e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6R—stomach cancer	2.4e-05	0.000326	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPP2R1A—stomach cancer	2.39e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APC—stomach cancer	2.39e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—RHOA—stomach cancer	2.39e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HSPB1—stomach cancer	2.38e-05	0.000323	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGTR2—stomach cancer	2.38e-05	0.000323	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BMP2—stomach cancer	2.35e-05	0.00032	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—F2R—stomach cancer	2.35e-05	0.00032	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6R—stomach cancer	2.35e-05	0.000319	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTP1—stomach cancer	2.35e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—RHOA—stomach cancer	2.34e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRB2—stomach cancer	2.33e-05	0.000316	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—HMOX1—stomach cancer	2.32e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKR1C3—stomach cancer	2.32e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—MAPK3—stomach cancer	2.29e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PPP2R1A—stomach cancer	2.28e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRB2—stomach cancer	2.28e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PPP2R1A—stomach cancer	2.23e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCB—stomach cancer	2.22e-05	0.000302	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6R—stomach cancer	2.22e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ANXA1—stomach cancer	2.21e-05	0.000301	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TYMS—stomach cancer	2.18e-05	0.000297	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—MAPK1—stomach cancer	2.18e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EGFR—stomach cancer	2.18e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—RHOA—stomach cancer	2.17e-05	0.000295	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTM1—stomach cancer	2.16e-05	0.000293	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB1—stomach cancer	2.14e-05	0.000291	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—RHOA—stomach cancer	2.12e-05	0.000289	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SMAD4—stomach cancer	2.12e-05	0.000288	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—stomach cancer	2.1e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CA—stomach cancer	2.08e-05	0.000283	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SERPINE1—stomach cancer	2.08e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SMAD4—stomach cancer	2.07e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—KRAS—stomach cancer	2.05e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—stomach cancer	2.05e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RPS6—stomach cancer	2.05e-05	0.000278	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ERCC2—stomach cancer	2.03e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCB—stomach cancer	2.01e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FYN—stomach cancer	2.01e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6ST—stomach cancer	2.01e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RHOA—stomach cancer	2e-05	0.000272	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—stomach cancer	1.98e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FYN—stomach cancer	1.97e-05	0.000268	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—stomach cancer	1.91e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—stomach cancer	1.9e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CA—stomach cancer	1.89e-05	0.000257	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGFR2—stomach cancer	1.89e-05	0.000257	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HBEGF—stomach cancer	1.88e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—stomach cancer	1.86e-05	0.000253	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ERBB2—stomach cancer	1.85e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGFR2—stomach cancer	1.85e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6R—stomach cancer	1.79e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	1.78e-05	0.000242	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—stomach cancer	1.76e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—stomach cancer	1.76e-05	0.000239	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—stomach cancer	1.75e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRAS—stomach cancer	1.75e-05	0.000237	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB2—stomach cancer	1.74e-05	0.000236	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS2—stomach cancer	1.73e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1B—stomach cancer	1.72e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	1.7e-05	0.000231	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS2—stomach cancer	1.69e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—stomach cancer	1.68e-05	0.000228	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—stomach cancer	1.67e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—stomach cancer	1.67e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—stomach cancer	1.64e-05	0.000223	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCND1—stomach cancer	1.64e-05	0.000223	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—stomach cancer	1.64e-05	0.000223	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—JUN—stomach cancer	1.63e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RHOA—stomach cancer	1.62e-05	0.00022	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—stomach cancer	1.6e-05	0.000217	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—stomach cancer	1.59e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6ST—stomach cancer	1.59e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1A—stomach cancer	1.58e-05	0.000215	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SMAD4—stomach cancer	1.58e-05	0.000215	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	1.56e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—stomach cancer	1.56e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6ST—stomach cancer	1.56e-05	0.000211	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—stomach cancer	1.55e-05	0.00021	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—stomach cancer	1.55e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APC—stomach cancer	1.53e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FYN—stomach cancer	1.5e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APC—stomach cancer	1.49e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK3—stomach cancer	1.46e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK3—stomach cancer	1.43e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—stomach cancer	1.43e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	1.42e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6R—stomach cancer	1.42e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—stomach cancer	1.41e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR2—stomach cancer	1.41e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK1—stomach cancer	1.39e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—stomach cancer	1.39e-05	0.000189	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—stomach cancer	1.39e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6R—stomach cancer	1.39e-05	0.000189	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK1—stomach cancer	1.36e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—stomach cancer	1.36e-05	0.000185	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK3—stomach cancer	1.35e-05	0.000184	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—stomach cancer	1.33e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—stomach cancer	1.33e-05	0.000181	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—stomach cancer	1.33e-05	0.00018	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—KRAS—stomach cancer	1.31e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—stomach cancer	1.31e-05	0.000179	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—stomach cancer	1.3e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—stomach cancer	1.3e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS2—stomach cancer	1.29e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—KRAS—stomach cancer	1.29e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK1—stomach cancer	1.29e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—stomach cancer	1.28e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RHOA—stomach cancer	1.28e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—stomach cancer	1.27e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RHOA—stomach cancer	1.25e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—stomach cancer	1.25e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—stomach cancer	1.25e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—stomach cancer	1.24e-05	0.000169	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—stomach cancer	1.22e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KRAS—stomach cancer	1.21e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—stomach cancer	1.21e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—stomach cancer	1.19e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB2—stomach cancer	1.19e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6ST—stomach cancer	1.19e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	1.18e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB2—stomach cancer	1.16e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APC—stomach cancer	1.14e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—stomach cancer	1.12e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRAS—stomach cancer	1.12e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—stomach cancer	1.12e-05	0.000152	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—stomach cancer	1.1e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	1.1e-05	0.000149	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRAS—stomach cancer	1.09e-05	0.000149	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	1.09e-05	0.000148	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—stomach cancer	1.08e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	1.07e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—stomach cancer	1.07e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6R—stomach cancer	1.06e-05	0.000144	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCND1—stomach cancer	1.05e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—stomach cancer	1.05e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JUN—stomach cancer	1.05e-05	0.000142	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	1.04e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—stomach cancer	1.04e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRAS—stomach cancer	1.03e-05	0.00014	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCND1—stomach cancer	1.03e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JUN—stomach cancer	1.02e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—stomach cancer	1.02e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	1.01e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—stomach cancer	9.96e-06	0.000135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	9.92e-06	0.000135	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	9.92e-06	0.000135	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	9.9e-06	0.000135	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—stomach cancer	9.89e-06	0.000134	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—stomach cancer	9.88e-06	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—KRAS—stomach cancer	9.8e-06	0.000133	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—stomach cancer	9.68e-06	0.000132	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RHOA—stomach cancer	9.55e-06	0.00013	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—stomach cancer	9.45e-06	0.000128	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—stomach cancer	9.13e-06	0.000124	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—stomach cancer	9.04e-06	0.000123	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	9e-06	0.000122	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—stomach cancer	8.94e-06	0.000122	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—stomach cancer	8.85e-06	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB2—stomach cancer	8.84e-06	0.00012	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK3—stomach cancer	8.64e-06	0.000117	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK3—stomach cancer	8.46e-06	0.000115	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—stomach cancer	8.4e-06	0.000114	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—stomach cancer	8.39e-06	0.000114	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRAS—stomach cancer	8.33e-06	0.000113	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—stomach cancer	8.23e-06	0.000112	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK1—stomach cancer	8.22e-06	0.000112	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—stomach cancer	8.22e-06	0.000112	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	8.19e-06	0.000111	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK1—stomach cancer	8.05e-06	0.000109	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—stomach cancer	8.05e-06	0.000109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—stomach cancer	7.97e-06	0.000108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCND1—stomach cancer	7.81e-06	0.000106	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUN—stomach cancer	7.8e-06	0.000106	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KRAS—stomach cancer	7.76e-06	0.000106	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KRAS—stomach cancer	7.6e-06	0.000103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—stomach cancer	7.58e-06	0.000103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	7.56e-06	0.000103	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—stomach cancer	7.48e-06	0.000102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—stomach cancer	7.38e-06	0.0001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	7.13e-06	9.69e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	6.98e-06	9.49e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—stomach cancer	6.9e-06	9.38e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—stomach cancer	6.81e-06	9.26e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—stomach cancer	6.76e-06	9.18e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—stomach cancer	6.74e-06	9.17e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRAS—stomach cancer	6.6e-06	8.97e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRAS—stomach cancer	6.46e-06	8.78e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK3—stomach cancer	6.44e-06	8.76e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—stomach cancer	6.32e-06	8.58e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—stomach cancer	6.27e-06	8.52e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—stomach cancer	6.18e-06	8.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK1—stomach cancer	6.13e-06	8.33e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—stomach cancer	6.13e-06	8.33e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KRAS—stomach cancer	5.79e-06	7.87e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	5.32e-06	7.23e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—stomach cancer	5.15e-06	6.99e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRAS—stomach cancer	4.92e-06	6.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—stomach cancer	4.71e-06	6.4e-05	CbGpPWpGaD
